These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34582255)

  • 1. How Many Health Research Biobanks Are There?
    O'Donoghue S; Dee S; Byrne JA; Watson PH
    Biopreserv Biobank; 2022 Jun; 20(3):224-228. PubMed ID: 34582255
    [No Abstract]   [Full Text] [Related]  

  • 2. Finding the Value in Biobanks: Enhancing the CTRNet Locator.
    Matzke LA; Tarling TE; Gali B; Dee S; LeBlanc J; Vercauteren S; Watson PH
    Biopreserv Biobank; 2022 Apr; 20(2):132-137. PubMed ID: 34252293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conception and Implementation of an Austrian Biobank Directory Integration Framework.
    Hofer-Picout P; Pichler H; Eder J; Neururer SB; Müller H; Reihs R; Holub P; Insam T; Goebel G
    Biopreserv Biobank; 2017 Aug; 15(4):332-340. PubMed ID: 28380303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biobank networking and globalisation: perspectives and practices of Australian biobanks.
    Light E; Wiersma M; Dive L; Kerridge I; Lipworth W; Stewart C; Kowal E; Marlton P; Critchley C
    Aust Health Rev; 2021 Mar; 45(2):214-222. PubMed ID: 33212000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of biobanks on research outcomes in rare diseases: a systematic review.
    Garcia M; Downs J; Russell A; Wang W
    Orphanet J Rare Dis; 2018 Nov; 13(1):202. PubMed ID: 30419920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Australian Biobank Certification Scheme: A Study of Economic Costs to Participating Biobanks.
    Ling R; Rush A; Carter C; Carpenter J; Watson PH; Byrne JA; Searles A
    Biopreserv Biobank; 2018 Feb; 16(1):53-58. PubMed ID: 29215912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biobanking in health care: evolution and future directions.
    Coppola L; Cianflone A; Grimaldi AM; Incoronato M; Bevilacqua P; Messina F; Baselice S; Soricelli A; Mirabelli P; Salvatore M
    J Transl Med; 2019 May; 17(1):172. PubMed ID: 31118074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Do Biomedical Researchers Want from Biobanks? Results of an Online Survey.
    Rush A; Catchpoole DR; Reaiche-Miller G; Gilbert T; Ng W; Watson PH; Byrne JA
    Biopreserv Biobank; 2022 Jun; 20(3):271-282. PubMed ID: 34756100
    [No Abstract]   [Full Text] [Related]  

  • 9. Biobanks: transnational, European and global networks.
    Asslaber M; Zatloukal K
    Brief Funct Genomic Proteomic; 2007 Sep; 6(3):193-201. PubMed ID: 17916592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation of the Taiwan Biobank 3.0: vertical and horizontal integration.
    Lin JC; Hsiao WW; Fan CT
    J Transl Med; 2020 Aug; 18(1):304. PubMed ID: 32762757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biobank classification in an Australian setting.
    Rush A; Christiansen JH; Farrell JP; Goode SM; Scott RJ; Spring KJ; Byrne JA
    Biopreserv Biobank; 2015 Jun; 13(3):212-8. PubMed ID: 26035012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The landscape of biobanks in Poland-characteristics of Polish biobanking units at the beginning of BBMRI.pl organization.
    Chróścicka A; Paluch A; Kozera Ł; Lewandowska-Szumieł M
    J Transl Med; 2021 Jun; 19(1):267. PubMed ID: 34158056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Certification for biobanks: the program developed by the Canadian Tumour Repository Network (CTRNet).
    Matzke EA; O'Donoghue S; Barnes RO; Daudt H; Cheah S; Suggitt A; Bartlett J; Damaraju S; Johnston R; Murphy L; Shepherd L; Mes-Masson AM; Schacter B; Watson PH
    Biopreserv Biobank; 2012 Oct; 10(5):426-32. PubMed ID: 24845043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing Professionalization of Biobank Business Operations: Performance and Utilization.
    Henderson MK; Goldring K; Simeon-Dubach D
    Biopreserv Biobank; 2019 Jun; 17(3):213-218. PubMed ID: 31188630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transparency About Governance Contributes to Biobanks' Trustworthiness: Call for Action.
    Gille F; Axler R; Blasimme A
    Biopreserv Biobank; 2021 Feb; 19(1):83-85. PubMed ID: 33124891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter- and intra-biobank networks: classification of biobanks.
    Shickle D; Griffin M; El-Arifi K
    Pathobiology; 2010; 77(4):181-90. PubMed ID: 20616613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Access arrangements' for biobanks: a fine line between facilitating and hindering collaboration.
    Fortin S; Pathmasiri S; Grintuch R; Deschênes M
    Public Health Genomics; 2011; 14(2):104-14. PubMed ID: 20689244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions of legislation relating to the sharing of genomic biobank results with donors-a survey of BBMRI-ERIC biobanks.
    Brunfeldt M; Teare H; Soini S; Kääriäinen H
    Eur J Hum Genet; 2018 Mar; 26(3):324-329. PubMed ID: 29330544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transparency of Biobank Access in Canada: An Assessment of Industry Access and the Availability of Information on Access Policies and Resulting Research.
    Gibson SG; Axler RE; Lemmens T
    J Empir Res Hum Res Ethics; 2017 Dec; 12(5):310-325. PubMed ID: 28818009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bio-objectifying European bodies: standardisation of biobanks in the Biobanking and Biomolecular Resources Research Infrastructure.
    Tamminen S
    Life Sci Soc Policy; 2015; 11():13. PubMed ID: 26626620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.